01.06.2006 | Pharmaco-Economics
Cost-Effectiveness of Eplerenone in Patients with Left Ventricular Dysfunction after Myocardial Infarction—An Analysis of the EPHESUS Study from a Swiss Perspective
Erschienen in: Cardiovascular Drugs and Therapy | Ausgabe 3/2006
Einloggen, um Zugang zu erhalten